Navellier & Associates Inc Pfizer Inc Transaction History

Navellier & Associates Inc

$705 Million
Q3 2024

A detailed history of Navellier & Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Navellier & Associates Inc holds 14,618 shares of PFE stock, worth $393,370. This represents 0.06% of its overall portfolio holdings.

Number of Shares

14,618

Previous 14,618 -0.0%

Holding current value

$393,370

Previous $409,000 3.42%

% of portfolio

0.06%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $153,435 - $199,295	-5,872 Reduced 28.66%	14,618 $420,000
Q3 2023 Nov 09, 2023	BUY	$32.09 - $37.51 $657,524 - $768,579	20,490 New	20,490 $679,000
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $1.98 Million - $2.23 Million	-59,162 Closed	0 $0
Q4 2020 Feb 05, 2021	SELL	$33.47 - $42.56 $113,530 - $144,363	-3,392 Reduced 5.42%	59,162 $2.18 Million
Q3 2020 Nov 09, 2020	SELL	$31.75 - $37.25 $164,719 - $193,253	-5,188 Reduced 7.66%	62,554 $2.3 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $120,449 - $146,123	-3,999 Reduced 5.57%	67,742 $2.22 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $165,964 - $237,126	-6,140 Reduced 7.88%	71,741 $2.34 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $48,161 - $54,657	1,463 Added 1.91%	77,881 $3.05 Million
Q3 2019 Oct 16, 2019	BUY	$32.49 - $42.13 $174,406 - $226,153	5,368 Added 7.56%	76,418 $2.75 Million
Q2 2019 Jul 17, 2019	BUY	$36.98 - $41.52 $70,816 - $79,510	1,915 Added 2.77%	71,050 $3.08 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $8,812 - $9,682	-235 Reduced 0.34%	69,135 $2.94 Million
Q4 2018 Jan 15, 2019	BUY	$38.47 - $43.86 $18,734 - $21,359	487 Added 0.71%	69,370 $3.03 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $7,307 - $8,863	-212 Reduced 0.31%	68,883 $3.04 Million
Q2 2018 Aug 06, 2018	BUY	$32.98 - $35.16 $34,266 - $36,531	1,039 Added 1.53%	69,095 $2.51 Million
Q1 2018 May 21, 2018	BUY	$31.91 - $37.02 $1.84 Million - $2.14 Million	57,785 Added 562.6%	68,056 $2.42 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $14,102 - $14,962	424 Added 4.31%	10,271 $372,000
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $12,183 - $13,420	-393 Reduced 3.84%	9,847 $352,000
Q2 2017 Aug 24, 2017	BUY	N/A	10,240	10,240 $344,000

Others Institutions Holding PFE

# of Institutions

3,224

Shares Held

3.61B

Call Options Held

77.1M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $151B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.

Account

Navellier & Associates Inc Pfizer Inc Transaction History